Shifting paradigms: biopharmaceuticals versus low molecular weight drugs DJA Crommelin, G Storm, R Verrijk, L de Leede, W Jiskoot, WE Hennink International journal of pharmaceutics 266 (1-2), 3-16, 2003 | 292 | 2003 |
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application MJ Nell, GS Tjabringa, AR Wafelman, R Verrijk, PS Hiemstra, JW Drijfhout, ... Peptides 27 (4), 649-660, 2006 | 204 | 2006 |
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes JH Van Steenis, EM Van Maarseveen, FJ Verbaan, R Verrijk, ... Journal of controlled release 87 (1-3), 167-176, 2003 | 151 | 2003 |
Novel Controlled-Release Lemna-Derived IFN-α2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial LGJ De Leede, JE Humphries, AC Bechet, EJ Van Hoogdalem, R Verrijk, ... Journal of Interferon & Cytokine Research 28 (2), 113-122, 2008 | 107 | 2008 |
The effect of formulation parameters on the size of poly ((2-dimethylamino) ethyl methacrylate)-plasmid complexes JY Cherng, H Talsma, R Verrijk, DJA Crommelin, WE Hennink European journal of pharmaceutics and biopharmaceutics 47 (3), 215-224, 1999 | 83 | 1999 |
The effect of core composition in biodegradable oligomeric micelles as taxane formulations MG Carstens, PH de Jong, CF van Nostrum, J Kemmink, R Verrijk, ... European journal of pharmaceutics and biopharmaceutics 68 (3), 596-606, 2008 | 79 | 2008 |
Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide R Verrijk, IJH Smolders, N Bosnie, AC Begg Cancer research 52 (23), 6653-6656, 1992 | 66 | 1992 |
Single ocular injection of a sustained-release anti-VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model P Adamson, T Wilde, E Dobrzynski, C Sychterz, R Polsky, E Kurali, ... Journal of Controlled Release 244, 1-13, 2016 | 59 | 2016 |
A mechanistic Study on the Chemical and Enzymatic Degradation of PEG‐Oligo (ε‐caprolactone) Micelles MG Carstens, CF van Nostrum, R Verrijk, LGJ De Leede, DJA Crommelin, ... Journal of pharmaceutical sciences 97 (1), 506-518, 2008 | 58 | 2008 |
Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation KDF Vlugt-Wensink, R De Vrueh, MG Gresnigt, CM Hoogerbrugge, ... Pharmaceutical research 24 (12), 2239-2248, 2007 | 53 | 2007 |
Small Oligomeric Micelles Based on End Group Modified mPEG− Oligocaprolactone with Monodisperse Hydrophobic Blocks MG Carstens, JJL Bevernage, CF van Nostrum, MJ van Steenbergen, ... Macromolecules 40 (1), 116-122, 2007 | 47 | 2007 |
Modeling the release of proteins from degrading crosslinked dextran microspheres using kinetic Monte Carlo simulations KDF Vlugt-Wensink, TJH Vlugt, W Jiskoot, DJA Crommelin, R Verrijk, ... Journal of controlled release 111 (1-2), 117-127, 2006 | 43 | 2006 |
Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin R Verrijk, IJH Smolders, JG McVie, AC Begg Cancer chemotherapy and pharmacology 29 (2), 117-121, 1991 | 39 | 1991 |
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors V Gregoire, AC Begg, R Huiskamp, R Verrijk, H Bartelink Radiotherapy and Oncology 27 (1), 46-54, 1993 | 36 | 1993 |
In vitro degradation behavior of microspheres based on cross-linked dextran KDF Vlugt-Wensink, X Jiang, G Schotman, G Kruijtzer, A Vredenberg, ... Biomacromolecules 7 (11), 2983-2990, 2006 | 34 | 2006 |
Preparation and characterization of albumin-heparin microspheres HFM Cremers, G Kwon, YH Bae, SW Kim, R Verrijk, H Noteborn, J Feijen Biomaterials 15 (1), 38-48, 1994 | 31 | 1994 |
Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media NFAW Peek, MJ Nell, R Brand, T Jansen-Werkhoven, EJ van Hoogdalem, ... PloS one 15 (4), e0231573, 2020 | 29 | 2020 |
Hydrogels for the controlled release of pharmaceutical proteins EPO Erythropoietin Pharmaceutical technology, 2001 | 28 | 2001 |
Poly (ethylene glycol)− oligolactates with monodisperse hydrophobic blocks: Preparation, characterization, and behavior in water MG Carstens, CF van Nostrum, A Ramzi, JD Meeldijk, R Verrijk, ... Langmuir 21 (24), 11446-11454, 2005 | 23 | 2005 |
A comprehensive PC-based computer model for microdosimetry of BNCT R Verrijk, R Huiskamp, AC Begg, FJ Wheeler, PRD Watkins International journal of radiation biology 65 (2), 241-253, 1994 | 18 | 1994 |